TP53 and cancer: Another cause of the emergence of drug resistance is the increased expression of pro-inflammatory cytokines in the path of drug uptake by cancer cells, which affects the drug efficacy.16,21 Bauer et al28 reported that drug resistance is due to the low level of P53 and high level of Bcl-xL.